Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CrossAmerica Partners (CAPL) Operating Expenses (2016 - 2025)

Historic Operating Expenses for CrossAmerica Partners (CAPL) over the last 15 years, with Q3 2025 value amounting to $84.1 million.

  • CrossAmerica Partners' Operating Expenses fell 533.94% to $84.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $348.9 million, marking a year-over-year increase of 797.77%. This contributed to the annual value of $332.7 million for FY2024, which is 1130.35% up from last year.
  • CrossAmerica Partners' Operating Expenses amounted to $84.1 million in Q3 2025, which was down 533.94% from $87.9 million recorded in Q2 2025.
  • CrossAmerica Partners' 5-year Operating Expenses high stood at $92.8 million for Q1 2025, and its period low was $55.1 million during Q1 2021.
  • Its 5-year average for Operating Expenses is $74.7 million, with a median of $74.8 million in 2022.
  • Per our database at Business Quant, CrossAmerica Partners' Operating Expenses soared by 6985.51% in 2021 and then tumbled by 533.94% in 2025.
  • CrossAmerica Partners' Operating Expenses (Quarter) stood at $66.7 million in 2021, then grew by 4.16% to $69.5 million in 2022, then grew by 7.41% to $74.6 million in 2023, then increased by 12.82% to $84.2 million in 2024, then fell by 0.11% to $84.1 million in 2025.
  • Its Operating Expenses stands at $84.1 million for Q3 2025, versus $87.9 million for Q2 2025 and $92.8 million for Q1 2025.